Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral Therapy.

PLoS One · 2015 · PMC4567270 · PMID 26360703

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

of borderline significanceP = 0.07so close (0.05 < p ≤ 0.1)

The atazanavir C 12 was higher (median, 0.85 mg/L; range, 0.11–1.75) in patients with incident stones compared with patients without stones (median, 0.66 mg/L; range, 0.01–5.84), but the difference was of borderline significance ( P = 0.07).

also in 1,677 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.